Citation sources

Updated weekly. Details via Crossref

Crossref	Scopus	Google Scholar
7	8	Search

2024	The prognostic value and its relationship with immune infiltration of ACLY in clear cell renal cell carcinoma Translational Oncology Beibei Yin, Qiang Liu, Yabing Zheng, Huayu Gao, Yun Lin, Zuohui Zhao
2024	Mutational profile of primary clear cell renal cell carcinoma predicts recurrence and potential candidacy for adjuvant immune checkpoint inhibition F1000Research Panagiotis J. Vlachostergios, Maria Papathanassiou, Maria Anagnostou, Eleni Thodou, Ioannis Tamposis, Lampros Mitrakas, Ioannis Zachos, George K. Koukoulis, Maria Samara, Vassilios Tzortzis
2023	Prognostic and clinicopathological role of RACK1 for cancer patients: a systematic review and meta-analysis PeerJ Qiuhao Wang, Sixin Jiang, Yuqi Wu, You Zhang, Mei Huang, Yan Qiu, Xiaobo Luo
2023	Identification of potential biomarkers and candidate therapeutic drugs for clear cell renal cell carcinoma by bioinformatic analysis and reverse network pharmacology Medicine Zhuo Meng, Bo Yuan, Shuang Yang, Xiaotong Fu, Baoyue Zhang, Kun Xu, Pengfei Bao, Youliang Huang
2023	The novel role of LDHA/LDHB in the prognostic value and tumor-immune infiltration in clear cell renal cell carcinoma PeerJ Jie Chen, Fei Wu, Yehua Cao, Yuanxin Xing, Qingyong Liu, Zuohui Zhao
2023	Immunotherapy and Immune Infiltration in Patients with Clear Cell Renal Cell Carcinoma: A Comprehensive Analysis Genetics Research Lin Hou, Xinyue Liu
2022	mTOR-Mediated Regulation of Immune Responses in Cancer and Tumor Microenvironment Frontiers in Immunology Sahar Mafi, Behzad Mansoori, Shahram Taeb, Hossein Sadeghi, Reza Abbasi, William C. Cho, Davoud Rostamzadeh
	Additional cited-by details will be shown when available from Crossref